ARCHIVES

FDA News: FDA Lifts Clinical Hold On CTI’s Tosedostat

This article is from The Cancer Letter archive.

Vol. 40 No. 05 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

An Earmark For Pancreatic Cancer

August 3, 2012

DCT Board Approves Drug Development Recompetition

November 30, 1990

NCI Clarifies P01 Grant Application Dates

September 13, 1996

Schweiker Approves Chabner Appointment

September 10, 1982

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

March 25, 2011

Feinstein Slams Cancer Act Proposal, Calls White Paper Vague And Unrealistic.

October 19, 2001